Basma Adeem Medical company (9626) Fair Value & Analysis
Healthcare · SA · Market cap 138M SAR
Fair value as of: Aug 1, 2026
From 23 valuation models · updated today
Share price +10.4% over the past month.
Price vs Fair Value (8 months)
8‑month range 5.18 SAR – 6.90 SAR · fair‑value band 4.96 SAR – 8.00 SAR · the 6.90 SAR price screens above the 6.48 SAR fair value. As of Aug 1, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Basma Adeem Medical company (9626) currently trades at 6.90 SAR, while our model-based Fair Value estimate is 6.48 SAR, implying the stock looks roughly 6.1% fairly valued today. We read business quality at 67/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Basma Adeem Medical company generated revenue of 45.5M SAR at a net margin of 16.1%. Revenue grew 44.1% year over year. It earns a return on equity of 21.4%. The balance sheet holds a net cash position of 8.3M SAR. Fundamentals as of Aug 1, 2026
Our scenario range runs from 4.96 SAR (bear case) to 8.00 SAR (bull case); at 6.90 SAR, the current price sits within that range. The share trades about 1% below its 52-week high and 33% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -19% fair-value upside, at -6%, 9626 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 1, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Basma Adeem Medical company provides dental services in the Kingdom of Saudi Arabia. Its services include same day surgery; dermatology and laser; dental repair, restorations, and cosmetic dentistry; gum surgery and dental implant; root canal treatment; oral and dental health; pediatric dentistry; and maxillofacial surgery, as well as orthodontic treatment …
Full company description
Basma Adeem Medical company provides dental services in the Kingdom of Saudi Arabia. Its services include same day surgery; dermatology and laser; dental repair, restorations, and cosmetic dentistry; gum surgery and dental implant; root canal treatment; oral and dental health; pediatric dentistry; and maxillofacial surgery, as well as orthodontic treatment for dental, face, and jaw surgery. Basma Adeem Medical company was incorporated in 2012 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Basma Adeem Medical company reported revenue of 45.5M SAR in FY2025 versus 21.9M SAR in FY2022, a compound +27.5%/yr. Reported net income was 7.3M SAR in FY2025, compounding +24.5%/yr from FY2022.
Is 9626 fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 1, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$100.00 | R$25.67 | -74% |
| Fresenius SE FRE | €39.54 | €31.98 | -19% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.76 SGD | 1.28 SGD | -54% |
| Tenet Healthcare Corporation THC | $178.75 | $300.86 | +68% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.50 | R$46.04 | +42% |
| DaVita Inc DVAI34 | R$1,002 | R$1,038 | +4% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,305 | ₹2,546 | -69% |
| Fresenius Medical Care AG FMSC34 | R$112.00 | R$164.60 | +47% |
| Aier Eye Hospital Group 300015 | ¥8.54 | ¥6.73 | -21% |
Compare Basma Adeem Medical company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Basma Adeem Medical company (9626) overvalued or undervalued?
What is the fair value of 9626?
What is the quality score of 9626?
What is the revenue of Basma Adeem Medical company (9626)?
What is the net profit margin of 9626?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Basma Adeem Medical company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.